Crossmark Large Cap Value ETF (CLCV)

Currency in USD
28.54
-0.18(-0.63%)
Closed·
28.54-0.18(-0.63%)
·
Day's Range
28.5428.54
52 wk Range
24.4228.84

Key Statistics

Morning Star Rating
-
Risk Rating
-
Bid / Ask
-
Prev. Close
28.72
Price Open
28.54
Volume
164
Average Vol. (3m)
2,216
1-Year Change
-
Day’s Range
28.54-28.54
52-Week Range
24.42-28.84
Market Cap
130.30B
Expense Ratio
0.50%
How do you feel today about CLCV?
Vote to see community's results!
or

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Neutral
Moving Averages
Buy

Performance

Name
YTD
3M
1Y
3Y
5Y
10Y
Growth of 10001,0581,032----
Fund Return+5.84%+3.19%----
Rank in Category833726----
Percentile Rank7766----
FLEX3.78%137.86-4.00%3,965
CSCO3.75%118.21+2.32%5,768
WDC3.47%482.02-1.46%1,022
QCOM3.36%201.49+0.70%2,151
XOM2.91%157.92+3.36%2,960
BAC2.83%49.77-0.16%8,521
NVT2.78%169.01-2.85%2,440
DELL2.77%241.99-2.38%1,702
CVS2.56%95.89-1.30%4,227
VZ2.53%46.37-1.47%8,150

Crossmark ETF Trust - Crossmark Large Cap Value ETF is an exchange traded fund launched and managed by Crossmark Global Investments, Inc. It invests in public equity markets. The fund invests in stocks of companies operating across diversified sectors. The fund invests in value stocks of large-cap companies, within the market capitalization range of the Russell 1000 Value Index. It invests in stocks of companies that are deemed socially conscious in their business dealings. The fund employs fundamental and quantitative analysis to create its portfolio. The fund does not invest in stocks of companies operating across production, distribution, retail, supply or licensing of alcohol or related products, tobacco or related products, gambling, abortions and/or the production of drugs that are used to terminate pregnancy, leasing real estate to facilities providing abortions, scientific research using stem cells derived from human embryos, fetal tissue or human embryo cloning techniques, production of adult entertainment or materially involved in the distribution or retail of adult entertainment, production, distribution, retail, supply or licensing of psychoactive recreational cannabis or derivative products sectors. The fund employs external research to create its portfolio. Crossmark ETF Trust - Crossmark Large Cap Value ETF was formed on July 23, 2025 and is domiciled in the United States.

Industry
-
Sector
-
Equity Type
ETF

FAQ

How is the performance of CLCV?

As of May 16, 2026, CLCV is trading at a price of 28.54, with a previous close of 28.72. The stock has fluctuated within a day range of 28.54 to 28.54, while its 52-week range spans from 24.42 to 28.84.

What is the current price of CLCV?

The CLCV stock price today is 28.54.

Does CLCV Pay Dividends? What’s The Current Dividend Yield?

The Crossmark Large Cap Value dividend yield is 0.37%.

What is the CLCV expense ratio?

The expense ratio for CLCV is 0.50%.

What is the CLCV premarket price?

CLCV's last pre-market stock price is 28.72.

What is the CLCV after hours price?

CLCV's last after hours stock price is 28.54.

What is the P/E ratio of CLCV?

The P/E ratio for CLCV is 15.52.

What is CLCV?

CLCV is an ETF issued by Crossmark Inc and is listed and traded on the New York Stock Exchange.

From a Technical Analysis Perspective, Is CLCV a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

What is the CLCV market cap?

The market cap for CLCV is 15.41M.

When is the CLCV dividend date?

The next dividend date for CLCV is Dec 18, 2025.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.